Alagille Syndrome Market – Global Insights & Growth Outlook

The global Alagille Syndrome Market size was valued at USD 384.06 Billion in 2023 and is projected to reach USD 718.05 Billion by 2032, growing at a CAGR of 7.2% from 2024 to 2032.

Alagille Syndrome is a rare inherited disease that implicated most organs of the body but it is mostly evident on the liver, heart organs and bile ducts. The disease is marked by one or many clinical symptoms such as liver disease brought about by scarcity of bile duct, heart problems and facial dysmorphism. Alagille Syndrome, involving only JAG1 or both the JAG1 and NOTCH2 genes, has proven to be highly variable in its presentation between individual patients. Diagnostic measures carried out on patients at an early stage of development often require proper treatment to help them recover from the condition thereby having a better quality of life.